{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:45:21Z","timestamp":1790786721185,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dld.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:56:57Z","timestamp":1719921417000},"page":"2069-2076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-111X","authenticated-orcid":false,"given":"Tom","family":"Konikoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Loebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henit","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Libchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kopylov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Albshesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Weisshof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Ghersin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahinoam Glusman","family":"Bendersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Avni-Biron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifat","family":"Snir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar","family":"Banai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Broytman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leor","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E","family":"Ollech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.06.008_bib0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.06.008_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.06.008_bib0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","article-title":"Age and immunity: what is \"immunosenescence\"?","volume":"105","author":"Pawelec","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.dld.2024.06.008_bib0004","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of Response to Anti-TNFs: definition, epidemiology, and Management","volume":"7","author":"Roda","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2024.06.008_bib0005","first-page":"63","article-title":"Comparison of timing to develop anti-drug antibodies to infliximab and adalimumab between adult and pediatric age groups, males and females","volume":"27","author":"Trotta","year":"2022","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.06.008_bib0006","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/clpt.2011.328","article-title":"Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms","volume":"91","author":"Ordas","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.06.008_bib0007","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ibd\/izz001","article-title":"Real-world pattern of biologic use in patients with inflammatory bowel disease: treatment persistence, switching, and importance of concurrent immunosuppressive therapy","volume":"25","author":"Chen","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2024.06.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211010668","article-title":"Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience","volume":"14","author":"Macaluso","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2024.06.008_bib0009","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/apt.14422","article-title":"Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis","volume":"47","author":"Singh","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.06.008_bib0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ajg.2011.103","article-title":"Assessing response and loss of response to biological therapies in IBD","volume":"106","author":"Yanai","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.06.008_bib0011","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41395-018-0268-4","article-title":"Artificial intelligence-assisted gastroenterology- promises and pitfalls","volume":"114","author":"Ruffle","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.06.008_bib0012","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2024.06.008_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4915828","article-title":"Interactive K-means clustering method based on user behavior for different analysis target in medicine","volume":"2017","author":"Lei","year":"2017","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.dld.2024.06.008_bib0014","unstructured":"SHAP library on GitHub. 2018. 2021, at https:\/\/github.com\/slundberg\/shap.)"},{"key":"10.1016\/j.dld.2024.06.008_bib0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/gutjnl-2020-321799","article-title":"Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine","volume":"70","author":"Bibault","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.06.008_bib0016","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10620-019-05867-1","article-title":"Biologic use patterns and predictors for non-persistence and switching of biologics in patients with inflammatory bowel disease: a nationwide population-based study","volume":"65","author":"Jung","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.06.008_bib0017","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/apt.16525","article-title":"Predictors of drug survival: a cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register","volume":"54","author":"Visuri","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.06.008_bib0018","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2147\/PPA.S171363","article-title":"Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database","volume":"12","author":"Baer","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.dld.2024.06.008_bib0019","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ibd\/izy031","article-title":"Predicting corticosteroid-free biologic remission with vedolizumab in Crohn's Disease","volume":"24","author":"Waljee","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2024.06.008_bib0020","doi-asserted-by":"crossref","first-page":"16440","DOI":"10.1038\/s41598-021-96019-x","article-title":"Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis","volume":"11","author":"Miyoshi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2024.06.008_bib0021","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ecco-jcc\/jjv059","article-title":"Inflammatory bowel disease and the elderly: a review","volume":"9","author":"Taleban","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.06.008_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/nu14163294","article-title":"Anti-inflammatory diet prevents subclinical colonic inflammation and alters metabolomic profile of ulcerative colitis patients in clinical remission","volume":"14","author":"Keshteli","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.dld.2024.06.008_bib0023","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.06.008_bib0024","first-page":"1759","article-title":"Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification","volume":"90","author":"Seo","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.06.008_bib0025","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cgh.2022.08.016","article-title":"Multicenter cohort study of infliximab pharmacokinetics and therapy response in pediatric acute severe ulcerative colitis","volume":"21","author":"Whaley","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.06.008_bib0026","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/ecco-jcc\/jjab058","article-title":"Vedolizumab and anti-tumour necrosis factor alpha real-world outcomes in biologic-naive inflammatory bowel disease patients: results from the EVOLVE Study","volume":"15","author":"Bressler","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.06.008_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134488","article-title":"Vedolizumab is associated with longer drug sustainability compared to infliximab in moderate-to-severe ulcerative colitis: long-term real-world cohort data","volume":"12","author":"Konikoff","year":"2023","journal-title":"J Clin Med"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824008181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824008181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T09:18:20Z","timestamp":1732526300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824008181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1590865824008181"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.06.008","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}